Skip to main content
. 2020 Aug 12;295(42):14379–14390. doi: 10.1074/jbc.REV120.008387

Figure 4.

Figure 4.

Beneficial effects of SGLT2 inhibitors that have been observed in clinical and preclinical studies. Mechanistic trials to explain how these improvements may occur and how they may be interrelated are ongoing.